TNF and Miyoshi myopathy: In the secondary analysis comparing TNF-α inhibitor use to csDMARD only use, there were 55 MM cases diagnosed in csDMARD users who never took a b/tsDMARD, 20 events in patients after switching to a TNF-α inhibitor, and 2 MM events while on a non- TNF-α inhibitor.